TFF Pharmaceuticals Income Statement

Financials in millions EUR. Fiscal year is May - April.

Millions EUR. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Revenue	312.75	425.43	486.55	439.79	302.62
Revenue Growth	-26.49%	-12.56%	10.63%	45.33%	16.00%
Cost of Revenue	-	181.87	225.96	213.53	152.16
Gross Profit	312.75	243.53	265.3	230.23	153.32
Selling, General & Admin	-	163.21	158.42	137.7	103.7
Depreciation & Amortization Expenses	-	18.66	15.48	13.93	12.29
Other Operating Expenses	-	2.16	4.5	3.51	2.09
Operating Income	312.75	59.46	91.6	79.09	38.11
Interest Income	-	-	-	0.59	23.33
Interest Expense	-	-20.35	-16.51	-8.7	-11.06
Other Non-Operating Income (Expense)	-9.94	4.81	11.68	1.4	0.4
Total Non-Operating Income (Expense)	-9.94	-15.54	-4.83	-6.72	12.67
Pretax Income	302.81	43.92	86.77	72.37	50.78
Provision for Income Taxes	3.97	12.11	28.36	18.03	14.19
Net Income	298.84	31.81	58.41	54.33	36.59
Minority Interest in Earnings	-	1.11	1.96	1.51	0.73
Net Income to Common	8.8	30.71	56.45	52.82	35.86
Net Income Growth	-71.34%	-45.60%	6.87%	47.30%	78.93%
Shares Outstanding (Basic)	22	22	22	22	22
Shares Outstanding (Diluted)	22	22	22	22	22
Shares Change	-0.00%	-0.03%	-0.00%	-0.27%	-0.23%
EPS (Basic)	0.41	1.42	2.60	2.44	1.65
EPS (Diluted)	0.41	1.42	2.60	2.44	1.65
EPS Growth	-71.40%	-45.38%	6.56%	47.88%	79.35%

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Free Cash Flow	0	-17.53	-55.72	-29.16	17.98
Free Cash Flow Growth	-	-	-	-	-55.51%
Free Cash Flow Per Share	-	-0.81	-2.57	-1.35	0.83
Dividends Per Share	0.400	0.500	0.600	0.400	0.400
Dividend Growth	-20.00%	-16.67%	50.00%	0%	14.29%
Gross Margin	100.00%	57.24%	54.53%	52.35%	50.67%
Operating Margin	100.00%	13.98%	18.83%	17.98%	12.59%
Profit Margin	95.55%	7.48%	12.01%	12.35%	12.09%
FCF Margin	0.00%	-4.12%	-11.45%	-6.63%	5.94%
EBITDA	312.75	80.46	106.83	93.13	49.9
EBITDA Margin	100.00%	18.91%	21.96%	21.18%	16.49%
EBIT	312.75	59.46	91.6	79.09	38.11
EBIT Margin	100.00%	13.98%	18.83%	17.98%	12.59%
Effective Tax Rate	1.31%	27.57%	32.68%	24.92%	27.95%

SEC Filings: 10-K · 10-Q